CN102302703B - Medicament for treating chloasma - Google Patents

Medicament for treating chloasma Download PDF

Info

Publication number
CN102302703B
CN102302703B CN2011102392494A CN201110239249A CN102302703B CN 102302703 B CN102302703 B CN 102302703B CN 2011102392494 A CN2011102392494 A CN 2011102392494A CN 201110239249 A CN201110239249 A CN 201110239249A CN 102302703 B CN102302703 B CN 102302703B
Authority
CN
China
Prior art keywords
medicament
chloasma
medicine
treatment
semen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011102392494A
Other languages
Chinese (zh)
Other versions
CN102302703A (en
Inventor
王瑞霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011102392494A priority Critical patent/CN102302703B/en
Publication of CN102302703A publication Critical patent/CN102302703A/en
Application granted granted Critical
Publication of CN102302703B publication Critical patent/CN102302703B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a medicament for treating chloasma. The medicament is prepared by uniformly mixing selected angelica dahurica, white peony root, white silkworm, rhizoma atractylodis macrocephalae, coix seed, yam, bletilla striata, cortex dictamni, talc, kudzuvine root, semen cassia, pharbitis seed, tuckahoe and tree peony bark which have been cleaned by clean water, grinding into powder with 100 to 120 meshes and sterilizing. The medicament has the effects of invigorating spleen and excreting dampness, keeping yin qi and wei qi balance, promoting flow of qi and blood circulation, and expelling wind and removing toxin; and the medicament can fulfill the aim of no side effects and high cure rate when used for treating chloasma.

Description

A kind of medicine for the treatment of chloasma
Technical field
The present invention relates to a kind of medicine for the treatment of chloasma, particularly relate to a kind of medicine of the treatment chloasma for preparing take Chinese medicine as crude drug.
Background technology
Chloasma is also referred to as chloasma hepaticum and butterfly spot, is a kind of symptom of facial melanosis, is the pigmentation spots that occurs in face.Mainly because of the female incretion imbalance, stress is large for chloasma, lacks the stimulation of vitamin and external chemicals in various diseases (hepatic and kidney function obstacle, gynaecopathia, diabetes) etc. and the body and causes.
Chloasma serious harm women happiness, chloasma spreads not second to indirectly disfeaturing face, therefore most women lose beauty and glamour, become self-doubt, depression is felt oneself inferior, and is unwilling in the face of friend, and the emotion of constraining in the course of time causes endocrine further to be lacked of proper care, expedite the emergence of more melanin and be deposited in face, so just caused the more long more phenomenons of chloasma.
At present the treatment primary disease be divided into the methods such as dietetic therapy, medication, naturopathy, but how undesirable therapeutic effect is, and wherein naturopathy is expensive and cure the symptoms, not the disease; The dietetic therapy onset is slow, need to take good care of for a long time; The Western medicine side effect is large.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of chloasma, this medicine is comprised of Chinese medicine, has spleen invigorating eliminating dampness by diuresis, harmonizing yingfen and weifen, promoting flow of QI and blood, an effect of the detoxifcation of dispeling the wind, can play the treatment of chloasma have no side effect, purpose that cure rate is high.
Medicine of the present invention is that the Chinese medicine by following parts by weight is that crude drug prepares:
The Radix Angelicae Dahuricae 5~9 Radix Paeoniae Albas 6~10 Bombyx Batryticatus 6~10
The Rhizoma Atractylodis Macrocephalae 6~10 Semen Coiciss 6~10 Rhizoma Dioscoreaes 6~10
The Pseudobulbus Bletillae (Rhizoma Bletillae) 4~8 Cortex Dictamni 4~6 Talcums 4~8
Radix Puerariae 5~9, Semen Cassiae 4~6 Semen Pharbitidiss 4~8
Poria 6~10 Cortex Moutans 4~6.
The concrete preparation method of medicine of the present invention being made powder is:
Said medicine is cleaned mix homogeneously by described parts by weight, be ground into 100~120 purpose medicated powder, sterilization makes the powder product.
The using method of powder of the present invention is: with milk (glycerol, Oleum sesami) powder of the present invention is reconciled into paste, evenly smear the affected part.
The traditional Chinese medical science thinks that the pathogenic factor of chloasma is impairment caused by overstrain spleen soil, the deficiency-weakness of spleen-QI inability of food and drink to be digested and transported is precise and tiny, so see lustreless complexion, to give birth in the insufficiency of the spleen then phlegm-damp, phlegm-damp and coagulation of QI-blood are among skin, can not evacuate, the coalescent speckle that forms, the mass-tone of yellow color referring to the spleen, temper stalwartness then yellow skin and evenly, bright, deficiency of spleen-QI is yellow skin and dark stagnating then, so see brown spot.The Therapeutic Principle should be the spleen invigorating eliminating dampness by diuresis, harmonizing yingfen and weifen, promoting flow of QI and blood, the detoxifcation of dispeling the wind.The Radix Angelicae Dahuricae is dispersed, the circulation of qi promoting promoting the circulation of blood; Radix Puerariae expelling pathogenic factors from muscles by diaphoresis, loosing the interspaces of skin and muscles; Bombyx Batryticatus dispelling pathogenic wind and eliminating phlegm, the circulation of qi promoting of stimulating the menstrual flow; The Radix Paeoniae Alba nourish blood yin fluid astringing, harmonizing yingfen and weifen; Rhizoma Dioscoreae invigorating the spleen and replenishing QI, transporting phlegm-damp; The Poria promoting diuresis to eliminate damp pathogen; The Semen Coicis promoting diuresis to eliminate damp pathogen; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, consolidating superficial resistance are driven evil; Pseudobulbus Bletillae (Rhizoma Bletillae) astringing to arrest bleeding, detumescence and promoting granulation; Cortex Moutan blood circulation promoting and blood stasis dispelling, blood circulation promoting; The Semen Pharbitidis relieving constipation by purgation; Talcum dampness removing sore; Cortex Dictamni heat clearing and damp drying, the detoxifcation of dispeling the wind; Semen Cassiae liver heat removing and eyesight improving, beneficial nourishing liver-YIN.All medicines share, the effect that can play spleen invigorating eliminating dampness by diuresis, harmonizing yingfen and weifen, promoting flow of QI and blood, dispel the wind and detoxify.The purpose that the treatment that is used for chloasma can be played and have no side effect, cure rate is high.
For further investigating clinical efficacy and the safety of medicine of the present invention, select 45 routine patient with chloasma that the curative effect of medicine of the present invention has been carried out clinical observation.
45 routine cases are divided into two groups at random, treatment group 25 examples, matched group 20 examples.The diagnostic criteria of " chloasma clinical diagnosis and criterion of therapeutical effect (revised draft in 2003) " that all cases is all formulated according to CAIM (Chinese Association Of Integrative Medicine) Dermatology Professional Committee pigment disease group is diagnosed as chloasma.
Diagnostic criteria
1, facial filbert to dark brown, well-defined patch, symmetry distributes usually, NIP performance and squama;
2, without obvious subjective symptoms;
3, the women is multiple, mainly occur in adolescence after;
4, the state of an illness can have seasonality, and the Chang Xiachong winter is light;
5, get rid of the pigmentation that Other diseases causes.
Methods of marking and standard: the scoring of skin lesion area: 0 is without skin lesion; 1 is area<2cm 22 is area 2~4 cm 23 is skin lesion area>4cm 2The scoring of skin lesion color: 0 is the normal colour of skin; 1 is filbert; 2 is brown; 3 is dark brown.Total mark=area scoring+color scoring.4, point system decline index calculation method: total mark before decline index=(total mark after total mark before the treatment-treatment)/treatment.
Therapeutic Method
Matched group adopts vitamin C, and is oral, one time 2,3 times on the one, the topical Retinoids frost is wiped the affected part every day outward 1 time simultaneously.Treatment group adopts powder agent medicine of the present invention to treat, and every day 2 times powder agent medicine of the present invention is reconciled into paste with milk, smears the affected part.30 days is a course for the treatment of, uses altogether 2 courses for the treatment of.
Criterion of therapeutical effect
According to the criterion of therapeutical effect in chloasma clinical diagnosis and the criterion of therapeutical effect (revised draft in 2003), cure: 1. naked eyes are looked the mottle area and are disappeared〉90%, color disappears substantially; 2. point system is calculated the rear decline index for the treatment of 〉=0.8; Produce effects: 1. naked eyes look the mottle area and disappear>60%, color is obviously thin out; 2. point system is calculated the rear decline index for the treatment of 〉=0.5.Invalid: 1. naked eyes look the mottle area and disappear<30%, change color is not obvious; 2. point system is calculated the rear decline index for the treatment of≤0.
The curative effect comparative result sees Table 1 after two groups of case treatments.
Curative effect relatively after the table 1 liang group case treatment
Group The example number Cure n(%) Produce effects n(%) Invalid n(%) Total effective rate n(%)
Matched group 20 5(25) 10(50) 5(25) 15(75)
Treatment group 25 16(64) 7(28) 2(8) 23(92)
Statistical result showed, the treatment group curative effect obviously is better than matched group, and two group differences are remarkable, P<0.05.
The specific embodiment
Embodiment 1
Get Radix Angelicae Dahuricae 50g, Radix Paeoniae Alba 60g, Bombyx Batryticatus 60g, Rhizoma Atractylodis Macrocephalae 60g, Semen Coicis 60g, Rhizoma Dioscoreae 60g, Pseudobulbus Bletillae (Rhizoma Bletillae) 40g, Cortex Dictamni 40g, Talcum 40g, Radix Puerariae 50g, Semen Cassiae 40g, Semen Pharbitidis 40g, Poria 60g, Cortex Moutan 40g mix homogeneously selected, that clear water is cleaned, be ground into 100~120 medicated powder, sterilization makes the powder product.
Embodiment 2
Get Radix Angelicae Dahuricae 70g, Radix Paeoniae Alba 80g, Bombyx Batryticatus 80g, Rhizoma Atractylodis Macrocephalae 80g, Semen Coicis 80g, Rhizoma Dioscoreae 80g, Pseudobulbus Bletillae (Rhizoma Bletillae) 60g, Cortex Dictamni 50g, Talcum 60g, Radix Puerariae 70g, Semen Cassiae 50g, Semen Pharbitidis 60g, Poria 80g, Cortex Moutan 50g mix homogeneously selected, that clear water is cleaned, be ground into 100~120 medicated powder, sterilization makes the powder product.

Claims (1)

1. medicine for the treatment of chloasma is that crude drug prepares by the Chinese medicine of following portions by weight:
The Radix Angelicae Dahuricae 5~9 Radix Paeoniae Albas 6~10 Bombyx Batryticatus 6~10
The Rhizoma Atractylodis Macrocephalae 6~10 Semen Coiciss 6~10 Rhizoma Dioscoreaes 6~10
The Pseudobulbus Bletillae (Rhizoma Bletillae) 4~8 Cortex Dictamni 4~6 Talcums 4~8
Radix Puerariae 5~9, Semen Cassiae 4~6 Semen Pharbitidiss 4~8
Poria 6~10 Cortex Moutans 4~6,
With milk, glycerol or Oleum sesami medicine is reconciled into paste, smear the affected part.
CN2011102392494A 2011-08-19 2011-08-19 Medicament for treating chloasma Expired - Fee Related CN102302703B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102392494A CN102302703B (en) 2011-08-19 2011-08-19 Medicament for treating chloasma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102392494A CN102302703B (en) 2011-08-19 2011-08-19 Medicament for treating chloasma

Publications (2)

Publication Number Publication Date
CN102302703A CN102302703A (en) 2012-01-04
CN102302703B true CN102302703B (en) 2013-04-03

Family

ID=45376685

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102392494A Expired - Fee Related CN102302703B (en) 2011-08-19 2011-08-19 Medicament for treating chloasma

Country Status (1)

Country Link
CN (1) CN102302703B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102671047B (en) * 2012-05-15 2014-03-19 何龙 Chinese medicinal composition for treating acne and chloasma

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000012A (en) * 2010-12-04 2011-04-06 曾宇 Formula of mask for whitening and lightening spots

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000012A (en) * 2010-12-04 2011-04-06 曾宇 Formula of mask for whitening and lightening spots

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
邓燕,等.调和气血美白汤配合外用玉容散治疗黄褐斑42例疗效观察.《时珍国医国药》.2007,第18卷(第7期),1739-1740. *

Also Published As

Publication number Publication date
CN102302703A (en) 2012-01-04

Similar Documents

Publication Publication Date Title
CN102091203B (en) External traditional Chinese medicine preparation for treating refractory wound and preparation method thereof
CN102284051B (en) Medicine for treating chloasma
CN101019948A (en) Acne treating compound Chinese medicine prepn
CN102228485A (en) Composition for burn rehabilitation and preparation method thereof
CN102846803A (en) External application drug for treating beriberi
CN101897868B (en) Chinese medicinal composition for treating psoriasis and preparation method thereof
CN105477129A (en) External-use plaster for psoriasis and preparation method thereof
CN102302703B (en) Medicament for treating chloasma
CN113244356A (en) Traditional Chinese medicine composition for treating psoriasis
CN104800427A (en) Burn and scald recovery application and preparation method thereof
CN105233152A (en) Traditional Chinese medicinal composition having function of relieving pain and preparation method of traditional Chinese medicinal composition
CN110772590A (en) Chinese medicinal compound preparation for treating verruca plantaris
CN112704702B (en) Traditional Chinese medicine composition for treating scalp psoriasis and preparation method thereof
CN101554432B (en) Fumigating and washing medicine for curing hemorrhoids
CN102641409B (en) Traditional Chinese medicine for treating onychomycosis
CN102138987A (en) Traditional Chinese medicine composition for treating seborrhoeic dermatitis
CN108066738B (en) Ointment for treating gouty arthritis and preparation method thereof
CN106039167A (en) Medicine composition for treating tinea manuum and tinea pedis, preparation method and application thereof
CN105343247A (en) Traditional Chinese medicinal composition having function of relieving pain and preparation method of traditional Chinese medicinal composition
CN1284554C (en) Medicine for treating acute urticaria
CN106581380A (en) External preparation capable of promoting blood circulation to remove blood stasis and preparation method of external preparation
CN112439006A (en) Traditional Chinese medicine composition and tincture for treating intractable neurodermatitis and preparation method thereof
CN104491683A (en) Traditional Chinese medicine composition for treating verruca plana and preparation method of traditional Chinese medicine composition
CN103372158A (en) Composition for promoting blood circulation to remove meridian obstruction
CN118831119A (en) Ginseng and broom cypress fruit pill

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130403

Termination date: 20130819